Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y.
A number of neuropeptide Y (NPY) receptor subtypes, including the recently cloned Y5 receptor, have been implicated in the stimulation of food intake. In the present study, Y5 receptor antisense oligodeoxynucleotides (ODNs) were used to assess the potential involvement of the Y5 receptor in the regulation of spontaneous as well as NPY-induced food intake. Repeated central administration of Y5 antisense ODN significantly decreased spontaneous food intake and subsequently resulted in a significant weight loss. Furthermore, Y5 antisense ODN pre-treatment significantly inhibited the robust feeding response elicited by central administration of NPY (5.3+/-0. 8 vs 1.08+/-0.28 g, vehicle+/-s.e.m. vs Y5 ODN+/-s.e.m.). The present results provide evidence that central Y5 receptors are involved in both spontaneous as well as NPY-induced food intake, which may prove to be a new therapeutic route in the treatment of obesity and other disorders of appetite.
Tang-Christensen
M
M
Institute of Medical Anatomy Section B, The Panum Institute, University of Copenhagen, Copenhagen, Denmark.
Kristensen
P
P
Stidsen
C E
CE
Brand
C L
CL
Larsen
P J
PJ
D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004435:Eating / Q000187:drug effects*; D007328:Insulin / Q000097:blood; D008297:Male; D009478:Neuropeptide Y / Q000494:pharmacology*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D018013:Receptors, Neuropeptide / Q000502:physiology*; D017476:Receptors, Neuropeptide Y / Q000235:genetics / Q000502:physiology*
D007328:Insulin; D009478:Neuropeptide Y; D016376:Oligonucleotides, Antisense; D018013:Receptors, Neuropeptide; D017476:Receptors, Neuropeptide Y; C100568:neuropeptide Y5 receptor